| pubmed-article:6649348 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6649348 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:6649348 | lifeskim:mentions | umls-concept:C0036945 | lld:lifeskim |
| pubmed-article:6649348 | lifeskim:mentions | umls-concept:C0205252 | lld:lifeskim |
| pubmed-article:6649348 | lifeskim:mentions | umls-concept:C1331532 | lld:lifeskim |
| pubmed-article:6649348 | lifeskim:mentions | umls-concept:C0077071 | lld:lifeskim |
| pubmed-article:6649348 | pubmed:issue | 14 | lld:pubmed |
| pubmed-article:6649348 | pubmed:dateCreated | 1984-1-7 | lld:pubmed |
| pubmed-article:6649348 | pubmed:abstractText | A new benzimidazole anthelmintic, triclabendazole (CGA-89317) was found to be highly efficient against mature and early immature Fasciola hepatica infections in sheep. At the dose rate of 2.5 mg/kg the efficiency was 90 and 98 per cent against flukes aged eight and 12 weeks respectively. At 5 mg/kg the drug was 92 and 98 per cent efficient against flukes aged four and eight weeks respectively and 100 per cent against 12-week-old flukes. An efficiency of 93 and 98 per cent was achieved against one-week-old flukes and 99 to 100 per cent against flukes aged two to four weeks at 10 mg/kg. At this dose rate the drug had 100 per cent efficiency against six-week-old flukes. If the dose was increased to 15 mg/kg, 98 per cent efficiency was achieved one day after infection. Triclabendazole was equally efficient when administered orally or by intraruminal or intra-abomasal injection. The maximum tolerated dose of 200 mg/kg was established. | lld:pubmed |
| pubmed-article:6649348 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6649348 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6649348 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6649348 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6649348 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6649348 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6649348 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6649348 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:6649348 | pubmed:issn | 0042-4900 | lld:pubmed |
| pubmed-article:6649348 | pubmed:author | pubmed-author:StrongM BMB | lld:pubmed |
| pubmed-article:6649348 | pubmed:author | pubmed-author:CrowfootP DPD | lld:pubmed |
| pubmed-article:6649348 | pubmed:author | pubmed-author:BorayJ CJC | lld:pubmed |
| pubmed-article:6649348 | pubmed:author | pubmed-author:SarasinGG | lld:pubmed |
| pubmed-article:6649348 | pubmed:author | pubmed-author:AllisonJ RJR | lld:pubmed |
| pubmed-article:6649348 | pubmed:author | pubmed-author:SchellenbaumM... | lld:pubmed |
| pubmed-article:6649348 | pubmed:author | pubmed-author:Von OrelliMM | lld:pubmed |
| pubmed-article:6649348 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6649348 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:6649348 | pubmed:volume | 113 | lld:pubmed |
| pubmed-article:6649348 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6649348 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6649348 | pubmed:pagination | 315-7 | lld:pubmed |
| pubmed-article:6649348 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:6649348 | pubmed:meshHeading | pubmed-meshheading:6649348-... | lld:pubmed |
| pubmed-article:6649348 | pubmed:meshHeading | pubmed-meshheading:6649348-... | lld:pubmed |
| pubmed-article:6649348 | pubmed:meshHeading | pubmed-meshheading:6649348-... | lld:pubmed |
| pubmed-article:6649348 | pubmed:meshHeading | pubmed-meshheading:6649348-... | lld:pubmed |
| pubmed-article:6649348 | pubmed:meshHeading | pubmed-meshheading:6649348-... | lld:pubmed |
| pubmed-article:6649348 | pubmed:meshHeading | pubmed-meshheading:6649348-... | lld:pubmed |
| pubmed-article:6649348 | pubmed:meshHeading | pubmed-meshheading:6649348-... | lld:pubmed |
| pubmed-article:6649348 | pubmed:meshHeading | pubmed-meshheading:6649348-... | lld:pubmed |
| pubmed-article:6649348 | pubmed:meshHeading | pubmed-meshheading:6649348-... | lld:pubmed |
| pubmed-article:6649348 | pubmed:meshHeading | pubmed-meshheading:6649348-... | lld:pubmed |
| pubmed-article:6649348 | pubmed:meshHeading | pubmed-meshheading:6649348-... | lld:pubmed |
| pubmed-article:6649348 | pubmed:year | 1983 | lld:pubmed |
| pubmed-article:6649348 | pubmed:articleTitle | Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole. | lld:pubmed |
| pubmed-article:6649348 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6649348 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6649348 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6649348 | lld:pubmed |
